Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001577014-26-000002

Director sold 834,302 shares at an average $19.75 ($16,477,388)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rhodes Jason P Director 2026-04-20 Sale 10b5-1 −71,676 $20.06 $1,437,821 1,886,751 I
Rhodes Jason P Director 2026-04-20 Sale 10b5-1 −142,604 $20.06 $2,860,636 5,554,904 I
Rhodes Jason P Director 2026-04-20 Sale 10b5-1 −1,401 $20.06 $28,104 14,561 I
Rhodes Jason P Director 2026-04-20 Sale 10b5-1 −56,368 $20.06 $1,130,742 1,402,200 I
Rhodes Jason P Director 2026-04-21 Sale 10b5-1 −71,499 $19.51 $1,394,945 1,815,252 I
Rhodes Jason P Director 2026-04-21 Sale 10b5-1 −142,253 $19.51 $2,775,356 5,412,651 I
Rhodes Jason P Director 2026-04-21 Sale 10b5-1 −1,398 $19.51 $27,275 13,163 I
Rhodes Jason P Director 2026-04-21 Sale 10b5-1 −56,228 $19.51 $1,097,008 1,345,972 I
Rhodes Jason P Director 2026-04-21 Sale 10b5-1 −769 $20.05 $15,418 1,814,483 I
Rhodes Jason P Director 2026-04-21 Sale 10b5-1 −1,530 $20.05 $30,677 5,411,121 I
Rhodes Jason P Director 2026-04-21 Sale 10b5-1 −15 $20.05 $301 13,148 I
Rhodes Jason P Director 2026-04-21 Sale 10b5-1 −605 $20.05 $12,130 1,345,367 I
Rhodes Jason P Director 2026-04-22 Sale 10b5-1 −75,866 $19.68 $1,493,043 1,738,617 I
Rhodes Jason P Director 2026-04-22 Sale 10b5-1 −150,942 $19.68 $2,970,539 5,260,179 I
Rhodes Jason P Director 2026-04-22 Sale 10b5-1 −1,485 $19.68 $29,225 11,663 I
Rhodes Jason P Director 2026-04-22 Sale 10b5-1 −59,663 $19.68 $1,174,168 1,285,704 I
Open-market sales · 834,302 sh · avg $19.75 · $16,477,388
Loading xslF345X06/form4-04222026_100417.xml…